Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system compared to radiofrequency ablation (RFA) for chronic low back pain (CLBP).
BRISBANE, Calif. - Pacira BioSciences, Inc. (NASDAQ:PCRX) announced results from a randomized 30-patient pilot study showing its iovera° cryoneurolysis treatment demonstrated better outcomes than ...
9don MSN
Doctors provide new hope for pancreatic cancer patients with less invasive radiofrequency ablation
UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and ...
UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and less-invasive treatment called radiofrequency ablation on a comorbid patient with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback